Healthcare

Feeling depressed linked to short-term increase in bodyweight, study finds

Clinical Research

Feeling depressed linked to short-term increase in bodyweight, study finds

Clinical Research
Healthcare

Feeling depressed linked to short-term increase in bodyweight, study finds

Clinical Research
Clinical Research
Clinical Research
Clinical Research

Feeling depressed linked to short-term increase in bodyweight, study finds

Clinical Research
Clinical Research
Clinical Research

Increases in symptoms of depression are associated with a subsequent increase in bodyweight when measured one month later, new research from the University of Cambridge has found.

The study, published today in PLOS ONE, found that the increase was greatest among people with overweight or obesity, but found no link between generally having greater symptoms of depression and higher bodyweight.

Research has suggested a connection between weight and mental health – with each potentially influencing the other – but the relationship is complex and remains poorly understood, particularly in relation to how changes in an individual’s mental health influence their bodyweight over time.

To help answer this question, researchers at Cambridge’s Medical Research Council (MRC) Epidemiology Unit examined data from over 2,000 adults living in Cambridgeshire, UK, who had been recruited to the Fenland COVID-19 Study.

Participants completed digital questionnaires on mental wellbeing and bodyweight every month for up to nine months during the COVID-19 pandemic (August 2020 – April 2021) using a mobile app developed by Huma Therapeutics Limited.

Questions assessed an individual’s symptoms of depression, anxiety and perceived stress. A higher score indicated greater severity, with the maximum possible scores being 24 for depression, 21 for anxiety and 40 for stress. The team then used statistical modelling to explore whether having poorer mental wellbeing than usual was related to changes in bodyweight one month later.

The researchers found that for every increment increase in an individual’s usual score for depressive symptoms, their subsequent weight one month later increased by 45g. This may seem small but would mean, for example, that in an individual whose depressive symptoms score rose from five to 10 (equal to an increase from ‘mild’ to ‘moderate’ depressive symptoms) it would relate to an average weight gain of 225g (0.225kg).

This effect was only observed in those individuals with overweight (defined as BMI 25-29.9kg/m 2 ) or with obesity (BMI of over 30kg/m 2 ). Individuals with overweight had on average an increase of 52g for each increment point increase from their usual depressive symptoms score and for those with obesity the comparable weight gain was 71g. The effect was not seen in those individuals with a healthy weight.

First author Dr Julia Mueller from the MRC Epidemiology Unit said: “Overall, this suggests that individuals with overweight or obesity are more vulnerable to weight gain in response to feeling more depressed. Although the weight gain was relatively small, even small weight changes occurring over short periods of time can lead to larger weight changes in the long-term, particularly among those with overweight and obesity.

“People with a high BMI are already at greater risk from other health conditions, so this could potentially lead to a further deterioration in their health. Monitoring and addressing depressive symptoms in individuals with overweight or obesity could help prevent further weight gain and be beneficial to both their mental and physical health.” The researchers found no evidence that perceived stress or anxiety were related to changes in weight.

Senior author Dr Kirsten Rennie from the MRC Epidemiology Unit said: “Apps on our phones make it possible for people to answer short questions at home more frequently and over extended periods of time, which provides much more information about their wellbeing. This technology could help us understand how changes in mental health influence behaviour among people with overweight or obesity and offer ways to develop timely interventions when needed.” Although previous studies have suggested that poor mental health is both a cause and consequence of obesity, the research team found no evidence that weight predicted subsequent symptoms of depression.
The research was supported by the Medical Research Council.

What’s a Rich Text element?

What’s a Rich Text element?

What’s a Rich Text element?

What’s a Rich Text element?
What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

  • bullet list item
  • bullet list item
  • bullet list item

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

  1. numbered list item
  2. numbered list item
  3. numbered list item
Image caption
Button Text
Author Name
Author Paragraph
Quote Text

Author Name

Quote Text

Author Name

Author Role

Author Name

Author Role

Author Paragraph
Download Title
Download Paragraph
Download Button Text
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Download
Download Whitepaper
Navigating the DCT transition: How to set up a digital-first trial that meets patient and study needs.
Download
No items found.
Table of Contents
Table of Content Link
Table of Content Link
Table of Content Link
Table of Content Link
Table of Content Link
Share this

Request a meeting

This field is required
This field is required
This field is required
This field is required
Country/Region ⃰
This field is required
I'm interested in

Huma is committed to respecting your privacy, and we’ll only use your personal details to provide information you have selected you’re interested in. Review our Privacy Policy for further information.

We’d love to send you our monthly newsletter about our latest work, research and events by email. We’ll always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes.

Submit
Thank you.
We will be in touch with you shortly.
Oops! Something went wrong while submitting the form.

Sources

COMPANY

About Huma

Huma began its journey in 2011, when the company was founded in London. Since then, Huma has grown to become a global healthcare company, spanning across multiple geographies and operating across four continents.

Learn more

Contact Us

Related Articles

See More
Article
Three ways that digital-first care can improve patient safety
During the COVID-19 pandemic the public were under quarantine orders preventing many patients from seeking care. A study on remote-patient monitoring showed that digital-first care provided a safe and effective option for patients with COVID-19.
Learn more
Remote Patient Monitoring
Clinical Research
Article
Decentralized trial sees increased adherence to heart medication
One of the first peer-reviewed assessments of a fully decentralized clinical trial (DCT) saw rapid recruitment (94% in 12 days), high engagement and that patients with low baseline increased their medication adherence.
Learn more
Digital Clinical Trials
Clinical Research

Related Blogs

See More
Doctors looking at the laptop
Blog
Diabetes goes digital
Explore this blog featuring the Q&A session with Edith Giemula to uncover the ways in which digital tools are revolutionising diabetes research.
Learn more
Blog
How we help tackle cardiac surgical waiting lists
The Covid-19 pandemic has overwhelmed healthcare systems around the world, leading to significant backlogs on surgical waiting lists.
Learn more

Related White Papers

See More
A female nurse working on an iPad.
White Paper
Navigating the DCT transition
Learn how remote trial technology is changing the clinical trial landscape and key considerations when including DCT components in your study protocols.
Learn more

Related Ebooks

See More
Ebook
Welcome to next-generation digital-first care and research
Deliver more personalised digital-first care and research with the first disease agnostic enterprise platform to achieve EU MDR Class IIb certification1.
Learn more
Ebook
What does FDA 510(k) Class II mean for Huma and our partners
Deliver more personalised digital-first care and research with our enterprise platform which now has FDA 510 (K) Class II clearance for any physician-specified condition.
Learn more